Walbro Engineering Manager, New Product Development Brad Roche joins host Tyler Kern to outline how the company is doing its part to assist medical personnel on the front lines of the battle against the global COVID-19 pandemic.
On this episode of Talking Shop with Walbro, host Tyler Kern was joined by Walbro Engineering Manager, New Product Development Brad Roche for a special discussion about how the company is helping those on the front lines of the fight against the COVID-19 pandemic.
Walbro has created an aerosol shield for nurse anesthetists and anesthesiologists to utilize during intubation, which protects these front-line healthcare workers from aerosol particles potentially spreading the novel coronavirus.
The product addresses a critical need for personal protective equipment, or PPE, that has been exposed by the accelerated spread of the virus.
“Through some brainstorming that we did, we tried to identify a lot of things that we could help with, then we started reaching out to medical professionals,” Roche said. “Through their guidance and feedback, we’ve created this device, which is largely based on something people are building in their garages. We thought we could bring a level of professionalism to it and make it a lot more durable, a lot more usable and (make it) last a lot longer for medical professionals.”
The entire process of engaging in this transition to supporting the medical community took less two weeks, with the initial brainstorm coming in mid-March, further consultation and improvements aimed at mass production toward the end of the month, and the first prototype-tooled version finalized on March 27.
Though Walbro was able to convert a plant typically manufacturing products like fuel tanks into a viable location for the production of these shields, Roche said the real heroes are those serving our global community on the leading edge of the fight against COVID-19. Learn more today at https://www.walbro.com/aerosol-shield/.
For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
As pharmaceutical innovation accelerates, the margin for error narrows, making quality assurance not just a regulatory necessity but a public good. Benchmark’s mission sits at the intersection of progress and protection—helping manufacturers stay aligned with FDA standards so life-saving therapies reach patients faster and safer. By keeping cleanrooms compliant and companies out of trouble, Benchmark…
Being part of the Benchmark Products team today means working at the intersection of precision manufacturing and deeply human collaboration, especially in the high-stakes world of cleanroom and sterility assurance solutions. As the organization grows, employees describe a culture that still feels familial—one where clear communication, personal accountability, and genuine care for customers drive…
In a media landscape increasingly shaped by privacy constraints, data clean rooms have emerged as a quiet but powerful way for brands to collaborate without exposing sensitive information, even if, as Will Sepsis quips, some partners would still prefer that “ignorance is bliss.” That tension—between curiosity and caution—captures the moment we’re in, where understanding…
At Benchmark Products, where cleanroom precision is part of everyday work, professionals often discover that specialized knowledge doesn’t always translate neatly into casual conversations—especially when friends jokingly wonder if you’ll critique their homes or turn them into germaphobes. The reality is that cleanroom science is about controlled environments and risk mitigation at an industrial scale,…
Episode 4 of The Future of Patient Monitoring takes a step back from infrastructure and innovation to explore something deeper: the people behind the technology—and what they’ve learned through years of building smarter systems. Part of the Health and Life Sciences at the Edge podcast series, this conversation is led by Intel’s Kaeli Tully,…
As hospitals across the U.S. shorten length of stay and push more recovery into the home, families are increasingly left to manage complex care needs without formal training or support. Roughly one in five patients with chronic conditions like COPD or congestive heart failure is readmitted within 30 days—a cycle that costs the healthcare…
